FCOM 2025: Oral Mucosal Immunotherapy for Allergic Rhinitis
Oral mucosal immunotherapy [OMIT] represents an emerging approach in the management of allergic rhinitis, designed to enhance patient adherence and broaden therapeutic options beyond traditional subcutaneous and sublingual immunotherapy. This